CRISPR Therapeutics AG [CRSP] Chief Executive Officer makes an insider purchase of 19,582 shares worth 1.17 million.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics AG shares valued at $1,173,232 were sold by Kulkarni Samarth on Apr 15 ’24. At $59.91 per share, Kulkarni Samarth sold 19,582 shares. The insider’s holdings dropped to 208,122 shares worth approximately $11.69 million following […]
Wolfe Research initates CRISPR Therapeutics AG (CRSP) stock to a Peer perform
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million on Mar 15 ’24. In the deal valued at $72.48 per share,20,000 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 208,122 shares worth roughly $12.22 million. Then, Prasad Raju sold […]
CRISPR Therapeutics AG [CRSP] Chief Executive Officer makes an insider purchase of 20,000 shares worth 1.45 million.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics AG shares valued at $1,449,628 were sold by Kulkarni Samarth on Mar 15 ’24. At $72.48 per share, Kulkarni Samarth sold 20,000 shares. The insider’s holdings dropped to 208,122 shares worth approximately $13.09 million following […]
CRISPR Therapeutics AG [CRSP] Investment Appeal on the Rise
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million on Mar 15 ’24. In the deal valued at $72.48 per share,20,000 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 208,122 shares worth roughly $13.34 million. Then, Prasad Raju sold […]
CRSP Shares Experience Surge in Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $1,449,628 were sold by Kulkarni Samarth on Mar 15 ’24. At $72.48 per share, Kulkarni Samarth sold 20,000 shares. The insider’s holdings dropped to 208,122 shares worth approximately […]
News: CRISPR Therapeutics AG’s Chief Executive Officer Kulkarni Samarth reduceds 20,000 shares
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million on Mar 15 ’24. In the deal valued at $72.48 per share,20,000 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 208,122 shares worth roughly $14.19 million. Then, Prasad Raju sold […]
Selling Buzz: CRISPR Therapeutics AG [CRSP] Chief Executive Officer Kulkarni Samarth sells 20,000 shares of the company
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $1,449,628 were sold by Kulkarni Samarth on Mar 15 ’24. At $72.48 per share, Kulkarni Samarth sold 20,000 shares. The insider’s holdings dropped to 208,122 shares worth approximately […]
A company insider recently sold 20,000 shares of CRISPR Therapeutics AG [CRSP]. Should You also Consider to Sale?
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million on Mar 15 ’24. In the deal valued at $72.48 per share,20,000 shares were sold. As a result of this transaction, Kulkarni Samarth now holds 208,122 shares worth roughly $14.9 million. Then, Prasad Raju sold […]
